Trial intelligence / Profile preview

Panobinostat in Chemo-refractory Metastatic Gastric Cancer

NCT01528501Phase 2Terminated

Sponsor
Technical University of Munich
Start
Jun 2009
Primary completion
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of panobinostat in gastric cancer (GC), sponsored by Technical University of Munich. Started Jun 2009; status: terminated.

02

Drugs

panobinostat
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT01528501.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01528501.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call